PACIRA BIOSCIENCES - NOTE 2.375% 4/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q2 2022

Type / Class
Debt / NOTE 2.375% 4/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PACIRA BIOSCIENCES - NOTE 2.375% 4/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2022 Q2 $0 $0 -$154,308 0
2022 Q1 $8,190,000 $154,308 -$172,667,000 101.87% 4
2021 Q4 $172,535,500 $178,584,155 +$8,357,857 102.93% 29
2021 Q3 $158,986,500 $165,406,616 +$34,887,426 103.69% 31
2021 Q2 $124,619,582 $136,553,058 -$1,225,642 109.35% 36
2021 Q1 $125,579,346 $152,669,441 +$8,243,983 121.13% 36
2020 Q4 $122,677,520 $140,138,487 +$8,442,239 114.49% 43
2020 Q3 $115,120,086 $131,988,727 -$189,915,696 114.83% 35
2020 Q2 $283,647,339 $310,759,965 -$1,364,568 109.15% 44
2020 Q1 $285,755,360 $276,366,436 +$4,934,512 96.37% 44
2019 Q4 $280,576,288 $293,847,244 -$14,083,243 104.14% 45
2019 Q3 $294,953,833 $291,617,939 +$11,788,919 98.67% 44
2019 Q2 $282,748,866 $291,190,761 +$363,257 102.58% 42
2019 Q1 $282,038,557 $278,010,362 -$35,182,420 98.48% 36
2018 Q4 $316,973,555 $314,837,901 +$28,804,137 99.43% 43
2018 Q3 $287,741,516 $305,232,750 -$8,476,476 106.0% 36
2018 Q2 $298,977,117 $278,429,391 -$18,599,374 93.06% 35
2018 Q1 $319,325,460 $292,859,363 +$292,859,363 91.5% 29